Physician

Gregg E. Franklin, MD

According to 2025 Medicare claims, Gregg Franklin, MD (NPI: 1124018353) practices radiation oncology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (NPI: 1164475232; TIN: 850367056) and primary practice location at 87109-4495.

Franklin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 290 traditional Medicare patients, billed 12,580 HCPCS/CPT codes, and received $1,937,515 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 255 prescription claims across 91 beneficiaries totaling $12,663 in drug costs, led by Tolterodine Tartrate (Tolterodine Tartrate). 2018 DME data shows 24 claims. Open Payments data shows 14 records totaling $9,271. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $644,266 to $1,937,515. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $8,483 to $12,663. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $644,266 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $740,433 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $663,513 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $848,623 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $997,461 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $644,942 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $915,675 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,450,953 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,678,096 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,937,515 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201532111,026$644,266
201638511,700$740,433
201738310,971$663,513
201837012,731$848,623
201936313,700$997,461
20203057,061$644,942
20212725,899$915,675
202228012,559$1,450,953
202327315,525$2,678,096
202429012,580$1,937,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$29K2015 Drug cost: $8,483 (USD; Tot_Drug_Cst)2016 Drug cost: $28,795 (USD; Tot_Drug_Cst)2017 Drug cost: $6,242 (USD; Tot_Drug_Cst)2018 Drug cost: $8,251 (USD; Tot_Drug_Cst)2019 Drug cost: $17,529 (USD; Tot_Drug_Cst)2020 Drug cost: $5,102 (USD; Tot_Drug_Cst)2021 Drug cost: $6,965 (USD; Tot_Drug_Cst)2022 Drug cost: $10,268 (USD; Tot_Drug_Cst)2023 Drug cost: $8,976 (USD; Tot_Drug_Cst)2024 Drug cost: $12,663 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201581198$8,483
201682228$28,795
201767191$6,242
201889273$8,251
201971242$17,529
202060169$5,102
202169210$6,965
202292234$10,268
202388271$8,976
202491255$12,663

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$558$1.1K2017 Medicare payment: $905 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $1,116 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R24$905
2018N/R24$1,116
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session86585$254
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more71104$88
77014Ct guidance for insertion of radiation therapy fields105722$87
77336Continuing radiation therapy consultation per week83178$64
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's105138$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tolterodine TartrateTolterodine Tartrate13655$1,059
Tamsulosin HclTamsulosin Hcl694,137$974
Ciprofloxacin HclCiprofloxacin Hcl37190$231
Lidocaine-PrilocaineLidocaine/Prilocaine11174$149

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$3,862Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.1$5,408Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gregg E. Franklin, MD?

Tedicare shows public-source Medicare data for Gregg E. Franklin, MD (NPI 1124018353), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregg E. Franklin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gregg E. Franklin, MD?

Gregg E. Franklin, MD is linked to NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (billing NPI 1164475232) in the available physician profile data.

Does Gregg E. Franklin, MD have Open Payments data?

Gregg E. Franklin, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.